These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7880028)

  • 1. [Criteria of evaluation of results of drug dependence substitution programs as a function of objectives and means: high threshold, low threshold, withdrawal...].
    Charpak Y
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():69-70. PubMed ID: 7880028
    [No Abstract]   [Full Text] [Related]  

  • 2. [Are maintenance substitution practices indicated in the framework of health care of drug addicts?].
    Déglon JJ
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():92-3. PubMed ID: 7880040
    [No Abstract]   [Full Text] [Related]  

  • 3. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of the development of substitution treatments and specialized care centers].
    Morel A
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():82-3. PubMed ID: 7880034
    [No Abstract]   [Full Text] [Related]  

  • 5. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
    Lott DC; Strain EC; Brooner RK; Bigelow GE; Johnson RE
    J Subst Abuse Treat; 2006 Sep; 31(2):187-94. PubMed ID: 16919747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Substitution study. Is it allowed to give placebos to junkies?].
    Ullmann R
    MMW Fortschr Med; 2003 Jul; 145(27-28):13. PubMed ID: 14587179
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing opioid dependence. Comparing buprenorphine with methadone.
    Cavacuiti C; Selby P
    Can Fam Physician; 2003 Jul; 49():876-7. PubMed ID: 12901482
    [No Abstract]   [Full Text] [Related]  

  • 9. Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
    Maremmani I; Pani PP; Pacini M; Perugi G
    J Subst Abuse Treat; 2007 Jul; 33(1):91-8. PubMed ID: 17588494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug interactions of methadone with CNS-active agents].
    Moreno Brea MR; Rojas Corrales O; Gibert-Rahola J; Micó JA
    Actas Esp Psiquiatr; 1999; 27(2):103-10. PubMed ID: 10380152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Substitution treatments. Pharmacological and legislative aspects].
    Bouchez J; Khan-Shaghaghi E; Beauverie P; Poisson N
    Soins; 1997; (612):7-10. PubMed ID: 9110879
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].
    Loustauneau A; Auriacombe M; Daulouede JP; Tignol J
    Ann Med Interne (Paris); 2002 Nov; 153(7 Suppl):2S31-6. PubMed ID: 12518080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can substitution practices be indicated in withdrawal programs for heroin addicts?].
    Boissonnas A
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():96-7. PubMed ID: 7880042
    [No Abstract]   [Full Text] [Related]  

  • 14. [How would the development of substitution treatments modify the care of drug addicts?].
    Charles-Nicolas A
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():79-81. PubMed ID: 7880033
    [No Abstract]   [Full Text] [Related]  

  • 15. [Substitution therapy in drug addictions].
    Auriacombe M; Fatseas M; Franques-Rénéric P; Daulouède JP; Tignol J
    Rev Prat; 2003 Jun; 53(12):1327-34. PubMed ID: 12920942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network].
    Modelon H; Frauger E; Laurenceau D; Thirion X; Mallaret M; Micallef J;
    Therapie; 2007; 62(4):337-46. PubMed ID: 17983559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dependence on psychotropic drugs and substitution treatment: recent trends. The OPPIDUM study of the Centers for Evaluation and Information on Drug Dependence (CEIP), October 1997].
    Thirion X; Micallef J; Guet F; Delarozière JC; Arditti J; Huntsman A; Sanmarco JL; Lagier G
    Therapie; 1999; 54(2):243-9. PubMed ID: 10394261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Maintenance treatment with high-dose buprenorphine: are the recommendations being followed?].
    Seyer D; Dif C; Balthazard G; Sciortino V
    Therapie; 1998; 53(4):349-54. PubMed ID: 9806004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction].
    Thirion X; Barrau K; Micallef J; Haramburu F; Lowenstein W; Sanmarco JL
    Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A10-7. PubMed ID: 10855372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportunistic diseases?] opportunisticinfections?].
    Boissonnas A
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():54-5. PubMed ID: 7880021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.